Role of Rip2 in development of tumor-infiltrating MDSCs and bladder cancer metastasis

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Zhang, Hanwei ^a   Chin, Arnold I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NERVE CELL ADHESION MOLECULE; PROTEIN KINASE RIP2; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; UNCLASSIFIED DRUG; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RIPK2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; B LYMPHOCYTE; B220+B LYMPHOCYTE; BLADDER CANCER; BLADDER METASTASIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; INCIDENCE; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NATURAL KILLER CELL; NONHUMAN; PARACRINE SIGNALING; PROTEIN EXPRESSION; SUPPRESSOR CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; WILD TYPE; ANIMAL; BLADDER TUMOR; BONE MARROW CELL; C57BL MOUSE; DEFICIENCY; METABOLISM; METASTASIS; PATHOLOGY; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; LYMPHOCYTES, TUMOR-INFILTRATING; MICE, INBRED C57BL; MYELOID CELLS; NEOPLASM METASTASIS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; TUMOR BURDEN; URINARY BLADDER NEOPLASMS;

EID: 84899624279     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094793     Document Type: Article

References (50)

1. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, et al. (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313: 1960-1964. (Pubitemid 44498003)
2. Sharma P, Shen Y, Wen S, Yamada S, Jungbluth A, et al. (2007) CD8 tumorinfiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proc Natl Acad Sci U S A 104: 3967-3972. (Pubitemid 47181562)
3. DeNardo DG, Brennan DJ, Rexhepaj E, Ruffell B, Shiao SL, et al. (2011) Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov 1: 54-67.
4. Fridman WH, Pagès F, Sautès-Fridman C, Galon J (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12: 298-306.
5. Iwasaki A, Medzhitov R (2010) Regulation of adaptive immunity by the innate immune system. Science 327: 291-295.
6. Chin AI, Miyahira AK, Covarrubias A, Teague J, Guo B, et al. (2010) Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance. Cancer Res 70: 2595-2603.
7. Heldwein KA, Liang MD, Andresen TK, Thomas KE, Marty AM, et al. (2003) TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG products. J Leukoc Biol 74: 277-286. (Pubitemid 38040425)
8. Simons MP, O'Donnell MA, Griffith TS (2008) Role of neutrophils in BCG immunotherapy for bladder cancer. Urol Oncol 26: 341-345. (Pubitemid 351885380)
9. Bertrand MJM, Lippens S, Staes A, Gilbert B, Roelandt R, et al. (2011) cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4). PLoS One 6: e22356.
10. Chin AI, Dempsey PW, Bruhn K, Miller JF, Xu Y, et al. (2002) Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 416: 190-194. (Pubitemid 34246478)
11. Kobayashi K, Inohara N, Hernandez LD, Galán JE, Núñez G, et al. (2002) RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416: 194-199. (Pubitemid 34246479)
12. Nembrini C, Kisielow J, Shamshiev AT, Tortola L, Coyle AJ, et al. (2009) The kinase activity of Rip2 determines its stability and consequently Nod1-and Nod2-mediated immune responses. J Biol Chem 284: 19183-19188.
13. Tigno-Aranjuez JT, Asara JM, Abbott DW (2010) Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses. Genes Dev 24: 2666-2677.
14. Park J-H, Kim Y-G, McDonald C, Kanneganti T-D, Hasegawa M, et al. (2007) RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. J Immunol 178: 2380-2386. (Pubitemid 46233437)
15. Elinav E, Strowig T, Henao-Mejia J, Flavell R (2011) Regulation of the antimicrobial response by NLR proteins. Immunity 34: 665-679.
16. Biswas A, Liu Y-J, Hao L, Mizoguchi A, Salzman NH, et al. (2010) Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc Natl Acad Sci U S A 107: 14739-14744.
17. Shaw PJ, Barr MJ, Lukens JR, McGargill M, Chi H, et al. (2011) Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity. Immunity 34: 75-84.
18. Abbott DW, Wilkins A, Asara JM, Cantley LC (2004) The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMO. Curr Biol 14: 2217-2227. (Pubitemid 40033358)
19. Li J, Tian J, Ma Y, Cen H, Leng R-X, et al. (2012) Association of RIP2 gene polymorphisms and systemic lupus erythematosus in a Chinese population. Mutagenesis 27: 319-322.
20. Hudson MA, Ritchey JK, Catalona WJ, Brown EJ, Ratliff TL (1990) Comparison of the Fibronectin-binding Ability and Antitumor Efficacy of Various Mycobacteria. Cancer Res 50: 3843-3847. (Pubitemid 20225593)
21. Shapiro A, Kelley DR, Oakley DM, Catalona WJ, Ratliff TL (1984) Technical Factors Affecting the Reproducibility of Intravesical Mouse Bladder Tumor Implantation during Therapy with Bacillus Calmette-Guérin. Cancer Res 44: 3051-3054. (Pubitemid 14081441)
22. Soloway MS (1977) Intravescial and systemic chemotherapy of urinary bladder cancer. Cancer Res 37: 2918-2929. (Pubitemid 8160449)
23. Jessen KA, Liu SY, Tepper CG, Karrim J, McGoldrick ET, et al. (2004) Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin. Breast Cancer Res 6: 157-69.
24. Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S, et al. (2005) Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med 11: 1314-1321. (Pubitemid 41752912)
25. Sevko A, Umansky V (2013) Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves. J Cancer 4: 3-11.
26. Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S (2007) Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 179: 977-983.
27. Wu J, Li J, Salcedo R, Mivechi NF, Trinchieri G, et al. (2012) The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma. Cancer Res 72: 3977-3986.
28. Zanzinger K, Schellack C, Nausch N, Cerwenka A (2009) Regulation of triggering receptor expressed on myeloid cells 1 expression on mouse inflammatory monocytes. Immunology 128: 185-195.
29. Ben-Baruch A (2012) The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFa and Chemokines. Cancer Microenviron 5: 151-164.
30. Chiu H-Y, Sun K-H, Chen S-Y, Wang H-H, Lee M-Y, et al. (2012) Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells. Cytokine 59: 423-432.
31. Fridlender ZG, Sun J, Mishalian I, Singhal S, Cheng G, et al. (2012) Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils. PLoS One 7: e31524.
32. Glass WG, Sarisky RT, Vecchio AM Del (2006) Not-so-sweet sixteen: the role of IL-16 in infectious and immune-mediated inflammatory diseases. J Interferon Cytokine Res 26: 511-520. (Pubitemid 44289894)
33. Jung YS, Liu X-W, Chirco R, Warner RB, Fridman R, et al. (2012) TIMP-1 induces an EMT-like phenotypic conversion in MDCK cells independent of its MMP-inhibitory domain. PLoS One 7: e38773.
34. Waight J, Hu Q, Miller A, Liu S, Abrams S (2011) Tumor-derived G-CSF facilitates neoplastic growth through a branulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS One 6.
35. Youn J-I, Nagaraj S, Collazo M, Gabrilovich DI (2008) Subsets of myeloidderived suppressor cells in tumor-bearing mice. J Immunol 181: 5791-5802.
36. Toh B, Wang X, Keeble J, Sim WJ, Khoo K, et al. (2011) Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol 9: e1001162.
37. Berx G, van Roy F (2009) Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol 1: a003129.
38. Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya a, Badve S, et al. (2007) NFkappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 26: 711-724. (Pubitemid 46204250)
39. Wu S, Kanda T, Nakamoto S, Imazeki F YO (2012) Knockdown of receptorinteracting serine/threonine protein kinase-2 (RIPK2) affects EMT-associated gene expression in human hepatoma cells. Anticancer Res 32: 3775-3783.
40. Kohrt HE, Nouri N, Nowels K, Johnson D, Holmes S, et al. (2005) Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med 2: e284.
41. Ribas AA, Hersey PP, Midleton MR, Gogas HH, Flaherty KT, et al. (2013) New challenges in endpoints for drug development in advanced melanoma. Clin Cancer Res 18: 336-341.
42. Philpott DJ, Girardin SE (2010) Nod-like receptors: sentinels at host membranes. Curr Opin Immunol 22: 428-434.
43. Couturier-Maillard A, Secher T, Rehman A, Normand S, De Arcangelis A, et al. (2013) NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest 123: 700-711.
44. Inohara N, del Peso L, Koseki T, Chen S, Núñez G (1998) RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J Biol Chem 273: 12296-12300. Rip2 in MDSCs and Bladder Cancer Metastasis PLOS ONE | www.plosone.org 9 April 2014 | Volume 9 | Issue 4 | e94793 (Pubitemid 28240597)
45. Magalhaes JG, Lee J, Geddes K, Rubino S, Philpott DJ, et al. (2011) Essential role of Rip2 in the modulation of innate and adaptive immunity triggered by Nod1 and Nod2 ligands. Eur J Immunol 41: 1445-1455.
46. Liu C, Li Y, Yu J, Feng L, Hou S, et al. (2013) Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil. PLoS One 8: e54841.
47. Yang W-C, Ma G, Chen S-H, Pan P-Y (2013) Polarization and reprogramming of myeloid-derived suppressor cells. J Mol Cell Biol 5: 207-209.
48. Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, et al. (2011) Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34: 566-578.
49. Brandau S, Trellakis S, Bruderek K, Schmaltz D, Stellar G, et al. (2011) Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J Leukoc Biol 89: 311-317.
50. Eruslanov E, Neuberger M, Daurkin I, Perrin GQ, Algood C, et al. (2012) Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer. Int J Cancer 130: 1109-1119.